All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis ; day:22 ; month:8 ; year:2024 ; pages:1-9
Molecular psychiatry ; (22.8.2024), 1-9
- Creator
-
Aymerich, Claudia
Salazar de Pablo, Gonzalo
Pacho, Malein
Pérez-Rodríguez, Violeta
Bilbao, Amaia
Andrés, Lucía
Pedruzo, Borja
Castillo-Sintes, Idoia
Aranguren, Nerea
Fusar-Poli, Paolo
Zorrilla, Iñaki
González-Pinto, Ana
González-Torres, Miguel Ángel
Catalán, Ana
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41380-024-02694-3
- URN
-
urn:nbn:de:101:1-2411111035588.716344253904
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aymerich, Claudia
- Salazar de Pablo, Gonzalo
- Pacho, Malein
- Pérez-Rodríguez, Violeta
- Bilbao, Amaia
- Andrés, Lucía
- Pedruzo, Borja
- Castillo-Sintes, Idoia
- Aranguren, Nerea
- Fusar-Poli, Paolo
- Zorrilla, Iñaki
- González-Pinto, Ana
- González-Torres, Miguel Ángel
- Catalán, Ana
- SpringerLink (Online service)
Other Objects (12)
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs